CS
PGEN icon

Credit Suisse’s Precigen PGEN Stock Holding History

Credit Suisse’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-140,874
Closed -$149K – 3233
2023
Q1 		$149K Buy
140,874
+26,932
+24% +$38.8K ﹤0.01% 3167
2022
Q4 		$173K Buy
113,942
+1,045
+0.9% +$1.8K ﹤0.01% 3223
2022
Q3 		$239K Buy
112,897
+578
+0.5% +$1.22K ﹤0.01% 3177
2022
Q2 		$150K Sell
112,319
-3,194
-3% -$4.74K ﹤0.01% 3427
2022
Q1 		$244K Buy
115,513
+3,944
+4% +$9.6K ﹤0.01% 3311
2021
Q4 		$414K Buy
111,569
+3,115
+3% +$13.4K ﹤0.01% 3951
2021
Q3 		$542K Buy
108,454
+3,945
+4% +$22.7K ﹤0.01% 3751
2021
Q2 		$681K Sell
104,509
-2,364
-2% -$16.5K ﹤0.01% 3646
2021
Q1 		$736K Sell
106,873
-46,861
-30% -$396K ﹤0.01% 3519
2020
Q4 		$1.57M Sell
153,734
-13,842
-8% -$89.7K ﹤0.01% 3014
2020
Q3 		$587K Buy
167,576
+73,255
+78% +$348K ﹤0.01% 3295
2020
Q2 		$471K Sell
94,321
-56,721
-38% -$193K ﹤0.01% 3364
2020
Q1 		$513K Buy
151,042
+57,871
+62% +$250K ﹤0.01% 3093
2019
Q4 		$510K Buy
93,171
+24,038
+35% +$135K ﹤0.01% 3557
2019
Q3 		$396K Sell
69,133
-2,084
-3% -$14.2K ﹤0.01% 3569
2019
Q2 		$546K Sell
71,217
-1,796
-2% -$9.67K ﹤0.01% 3347
2019
Q1 		$385K Buy
73,013
+690
+1% +$4.78K ﹤0.01% 3479
2018
Q4 		$473K Buy
72,323
+19,057
+36% +$214K ﹤0.01% 3290
2018
Q3 		$917K Sell
53,266
-13,364
-20% -$199K ﹤0.01% 2929
2018
Q2 		$928K Buy
66,630
+14,548
+28% +$246K ﹤0.01% 3064
2018
Q1 		$798K Sell
52,082
-421
-0.8% -$6.02K ﹤0.01% 3107
2017
Q4 		$604K Buy
52,503
+5,278
+11% +$78.6K ﹤0.01% 3336
2017
Q3 		$897K Sell
47,225
-36,810
-44% -$758K ﹤0.01% 3175
2017
Q2 		$2.02M Sell
84,035
-99,520
-54% -$2.18M ﹤0.01% 2222
2017
Q1 		$3.64M Buy
183,555
+133,992
+270% +$2.99M ﹤0.01% 1876
2016
Q4 		$1.19M Sell
49,563
-62,206
-56% -$1.73M ﹤0.01% 2878
2016
Q3 		$3.1M Buy
111,769
+71,266
+176% +$1.88M ﹤0.01% 2043
2016
Q2 		$989K Sell
40,503
-24,467
-38% -$694K ﹤0.01% 2928
2016
Q1 		$2.18M Buy
64,970
+31,426
+94% +$989K ﹤0.01% 2139
2015
Q4 		$1M Sell
33,544
-9,708
-22% -$327K ﹤0.01% 2809
2015
Q3 		$1.36M Sell
43,252
-53,662
-55% -$2.62M ﹤0.01% 2548
2015
Q2 		$4.69M Buy
96,914
+59,953
+162% +$2.53M ﹤0.01% 1791
2015
Q1 		$1.6M Sell
36,961
-10,519
-22% -$378K ﹤0.01% 2582
2014
Q4 		$1.25M Buy
47,480
+1,663
+4% +$36.5K ﹤0.01% 2945
2014
Q3 		$814K Sell
45,817
-49,741
-52% -$1.02M ﹤0.01% 3237
2014
Q2 		$2.29M Buy
95,558
+58,006
+154% +$1.18M ﹤0.01% 2599
2014
Q1 		$944K Sell
37,552
-546
-1% -$15.1K ﹤0.01% 3171
2013
Q4 		$867K Buy
38,098
+21,021
+123% +$425K ﹤0.01% 3389
2013
Q3 		$387K Buy
+17,077
New +$394K ﹤0.01% 3637

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Credit Suisse's PGEN Position: Q2 2023 in Review

Credit Suisse sold out of Precigen (PGEN) in Q2 2023, closing a stake of 140,874 shares — an estimated $149K sold.

Credit Suisse first reported a position in PGEN in Q3 2013 and held it in 39 quarters. The position peaked at $4.69M in Q2 2015. 138 funds tracked by Wall St. Rank hold PGEN as of Q2 2023.

  • Credit Suisse reported no remaining Precigen position as of Q2 2023 after selling out during the quarter.
  • Credit Suisse sold 140,874 Precigen shares in Q2 2023, an estimated $149K.
  • Credit Suisse first reported a position in Precigen in Q3 2013 and held it in 39 quarters.
  • Credit Suisse's Precigen position peaked at $4.69M in Q2 2015.
  • 138 funds tracked by Wall St. Rank held Precigen as of Q2 2023.

Based on Credit Suisse's 13F filing for Q2 2023, filed 11 Aug 2023.